Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial

Silk SE., Kalinga WF., Salkeld J., Mtaka IM., Ahmed S., Milando F., Diouf A., Bundi CK., Balige N., Hassan O., Mkindi CG., Rwezaula S., Athumani T., Mswata S., Lilolime NS., Simon B., Msami H., Mohamed M., David DM., Mohammed L., Nyaulingo G., Mwalimu B., Juma O., Mwamlima TG., Sasamalo IA., Mkumbange RP., Kamage JJ., Barrett JR., King LDW., Hou MM., Pulido D., Carnrot C., Lawrie AM., Cowan RE., Nugent FL., Roberts R., Cho J-S., Long CA., Nielsen CM., Miura K., Draper SJ., Olotu AI., Minassian AM.

DOI

10.1016/s1473-3099(24)00312-8

Type

Journal article

Journal

The Lancet Infectious Diseases

Publisher

Elsevier BV

Publication Date

10/2024

Volume

24

Pages

1105 - 1117

Permalink Original publication